A hantavirus outbreak aboard a cruise ship has prompted the CDC to issue guidance and initiate plans to evacuate American passengers, with quarantine expected in Nebraska. Health officials say the risk of the virus spreading to the general U.S. public remains low, though contact tracing efforts are underway.
The Centers for Disease Control and Prevention has classified a hantavirus outbreak connected to a cruise ship as a Level 3 emergency response. Cases have been identified among passengers who traveled aboard the MV Hondius near the Canary Islands, with health officials now monitoring affected individuals across multiple U.S. states.
A hantavirus outbreak aboard the MV Hondius cruise ship has resulted in at least one death and the evacuation of several passengers. The ship is now diverting to the Canary Islands after passengers were also offloaded at St. Helena. Health and maritime authorities are monitoring the situation as concerns grow about the rare but serious virus spreading in a closed environment.
At least three passengers have been evacuated from a cruise ship following a suspected hantavirus cluster, prompting a World Health Organization investigation. The vessel, identified as the MV Hondius, was denied permission to dock in the Canary Islands amid the outbreak. Health officials are examining whether the rare virus, typically not known to spread between humans, may have been transmitted onboard.
Three passengers aboard the MV Hondius cruise ship have died following a hantavirus outbreak. Health authorities are investigating the source and spread of the virus among those on board. Hantavirus is a rare but serious illness typically transmitted through contact with infected rodents or their droppings.
The World Health Organization has confirmed a hantavirus outbreak aboard a cruise ship in the Atlantic Ocean that has killed three people. Health authorities are investigating the source of the infections, which are unusual given that hantavirus is typically transmitted through contact with infected rodents rather than person-to-person spread.
President Trump has pulled his nomination of Casey Means for Surgeon General and replaced her with Nicole Saphier, a radiologist and Fox News medical contributor. The move comes after Means' nomination stalled in Congress amid scrutiny over her credentials and ties to the MAHA movement. Saphier is the third person Trump has nominated for the role.
The Justice Department has indicted David Morens, a former senior adviser to Dr. Anthony Fauci, on charges related to concealing communications tied to COVID-19 research. Prosecutors allege Morens circumvented federal open records requests. The case marks a significant development in ongoing scrutiny of government transparency during the pandemic.
The Supreme Court is considering whether federal pesticide law shields Bayer's Roundup herbicide from state-level cancer liability lawsuits. The cases center on glyphosate, Roundup's active ingredient, and whether EPA approval preempts jury verdicts against the company. The legal battle coincides with a contentious congressional hearing involving EPA Administrator Lee Zeldin.
The Trump administration has advanced a rule change to reclassify marijuana under federal law, a significant shift in drug policy with wide implications for public health, businesses, and investors. The move marks a rare area of bipartisan interest, though reactions across the political spectrum vary considerably.
The Trump administration has announced a drug pricing agreement with Regeneron, the latest in a series of pharmaceutical deals aimed at lowering costs for Medicaid patients. Under the deal, Regeneron will offer its hearing loss therapy for free. The agreement has drawn coverage across the political spectrum.
Health and Human Services Secretary Robert F. Kennedy Jr. faced tough questioning from both Republican and Democratic lawmakers during congressional hearings on the ongoing measles outbreak, vaccine policy, and proposed budget cuts to public health programs. Senators pressed Kennedy on his agency's response to the outbreak and his past skepticism of vaccines. Kennedy backed a bipartisan effort to improve early detection of future disease outbreaks.
Health and Human Services Secretary Robert F. Kennedy Jr. appeared before congressional committees to answer questions on vaccine policy, proposed CDC budget reductions, and Medicaid funding. The back-to-back hearings marked a significant moment of legislative scrutiny for Kennedy, who has drawn attention for his skepticism of established vaccine science. Lawmakers from both parties pressed Kennedy on the administration's direction for federal health agencies.
Defense Secretary Pete Hegseth has announced the end of the military's mandatory influenza vaccination requirement for U.S. troops. The move continues a broader rollback of military vaccine mandates that began with the repeal of the COVID-19 vaccine requirement. The policy change affects all branches of the armed forces.
President Trump signed an executive order directing the FDA to accelerate its review process for psychedelic-based treatments, with a particular focus on veterans suffering from PTSD. The order targets substances including ibogaine and aims to reduce regulatory timelines for therapies showing clinical promise. The move drew coverage across the political spectrum as an unusual area of bipartisan interest.
Health and Human Services Secretary Robert F. Kennedy Jr. appeared before congressional committees this week, facing pointed questioning from Democratic lawmakers over vaccine policy, public health agency cuts, and the direction of the Make America Healthy Again initiative. Republicans largely defended Kennedy's tenure. The hearings drew broad coverage across the political spectrum.
President Trump has nominated Erica Schwartz, a former deputy surgeon general, to serve as the next director of the Centers for Disease Control and Prevention. The nomination comes as the CDC has faced significant restructuring under the current administration. Schwartz would require Senate confirmation to assume the role.
President Trump signed an executive order placing 100% tariffs on brand-name pharmaceutical imports, framing the move as an effort to boost domestic drug manufacturing. The action, taken on the one-year anniversary of 'Liberation Day,' applies to brand-name drugs and is separate from measures targeting generic medications. Analysts and outlets across the political spectrum are covering the order's potential effects on drug prices and the pharmaceutical supply chain.
The FDA has approved Foundayo, an oral GLP-1 weight-loss pill developed by Eli Lilly, marking a significant milestone in obesity treatment. The approval offers patients a pill-based alternative to injectable GLP-1 drugs like Ozempic and Wegovy. The drug received speedy approval from the agency.
The Supreme Court ruled 8-1 to invalidate Colorado's ban on conversion therapy, siding with a therapist who challenged the law on free speech grounds. The near-unanimous decision has broad implications for similar laws in other states. The ruling was authored by a majority of justices across ideological lines.
The CDC issued a Level 1 travel advisory warning of higher-than-expected dengue fever cases among U.S. travelers returning from 16 countries, including Cuba, Colombia, and the Maldives. The alert comes as spring break travel peaks, with over 525 U.S. dengue cases already recorded in 2026. Fox News and public health outlets across the spectrum confirmed the advisory. About 1 in 20 infected individuals develops severe dengue, which can be life-threatening.
Vice President JD Vance convened the first meeting of a White House anti-fraud task force Friday targeting Medicare, Medicaid, unemployment insurance, and SNAP as programs with 'low confidence' in recipient verification. FTC Chair Andrew Ferguson serves as vice chair. Minnesota received immediate attention after the administration paused $260 million in Medicaid reimbursements over a daycare fraud investigation. NBC News confirmed the meeting; Breitbart has covered government waste extensively.
A University of Oslo study of 146,031 children published Wednesday in the journal Pediatrics found that babies whose mothers received COVID vaccination during pregnancy were approximately half as likely to be hospitalized for COVID in their first two months of life, with 24% reduced risk persisting through 5 months. The study found no increased risk of other infections, refuting claims about immune dysregulation. NPR covered the findings; the study's peer-reviewed data points are confirmed across health outlets on both sides of the vaccine debate.
The FDA approved Wegovy HD, a 7.2 mg formulation of semaglutide that is triple the previous maximum dose of 2.4 mg, on March 24 under its National Priority Voucher pilot program. Clinical trials showed patients lost an average of 20.7% of their body weight, compared to approximately 16% on the standard dose; about one-third of participants lost 25% or more. Fox News and health outlets across the spectrum confirmed the approval. The drug carries a stronger gastrointestinal side-effect profile at higher doses.
The U.S. Preventive Services Task Force — the independent panel whose recommendations determine which cancer screenings and preventive services insurers must cover at no cost under the ACA — has not met since March 2025 after three consecutive meetings were postponed or canceled. CNN reported the panel may be "abandoned" by HHS; Fox News covered the GOP Doctors Caucus backing a full overhaul to remove what they called 'woke distractions.' Both sides agree the panel's dysfunction has real consequences for patient care.
Senate Republicans on the Finance Committee have proposed Medicaid provisions in their version of the reconciliation bill that go further than the House-passed One Big Beautiful Bill, including a cost-sharing requirement per service for expansion enrollees and semi-annual eligibility re-checks. The CBO has estimated the combined changes could result in 8.6 million people losing Medicaid coverage. Fox News covered Trump's assurances that entitlements will not be cut; NPR and PBS NewsHour reported on the human stakes.
The White House announced the addition of three new prescription drugs to its TrumpRx discount platform — two Type 2 diabetes treatments and a COPD medication — reducing prices from hundreds of dollars to as low as $35 for cash-paying uninsured patients. NBCNews and a drug pricing analyst confirmed the significant per-unit discounts, but noted that only 7 percent of prescription users have visited the site and TrumpRx was never designed to serve insured patients. Fox Business and the Daily Wire frame TrumpRx as a meaningful step toward Trump's drug pricing promise.
The Centers for Medicare and Medicaid Services reversed a 2013 policy and began sharing Medicaid enrollee data with ICE for immigration enforcement in 28 states, after a San Francisco federal court limited but did not block the practice. A former Obama-era CMS official called it a '180-degree reversal' of longstanding protections. NPR reports eligible families with U.S. citizen children are dropping coverage out of fear, while Fox News has not prominently featured the story.
Fox News, NPR, and the FDA all confirm the same chain of events: FDA removed boxed cancer warnings from HRT products, demand spiked, and estrogen patches are now in shortage. The medical debate over the science continues.
The Centers for Medicare and Medicaid Services finalized a rule in September 2025 expanding Medicare coverage of GLP-1 drugs like Ozempic and Wegovy to treat obesity — not just diabetes. Fox News and NPR both confirmed the rule, agreeing on the 3.5 million newly eligible beneficiaries while diverging on the $7 billion annual cost.
The reconciliation bill signed July 4, 2025 — dubbed the 'One Big Beautiful Bill' — included an 80-hours-per-month work requirement for able-bodied Medicaid recipients ages 19-64. The Congressional Budget Office estimated 8.6 to 18 million people could lose coverage. Both Fox News and NPR confirmed the same CBO numbers while framing the policy in opposite terms.
Fox News, NPR, and Reuters agreed that the Supreme Court preserved the Affordable Care Act's system for requiring no-cost preventive services. The split was over institutional design and religious-freedom objections, not over the basic result.
The Senate confirmed Robert F. Kennedy Jr. as Secretary of Health and Human Services on February 13, 2025, by a 52-48 vote. Both Fox News and NPR confirmed the same sequence of post-confirmation changes — altered vaccine guidance, disbanded advisory panels, raw milk policy shifts — while evaluating them in opposite ways.
AP, Fox News, and NPR agreed that President Trump ordered the United States to withdraw from the World Health Organization on his first day back in office. The split was over whether the move restores accountability or weakens U.S. influence during global health emergencies.
The Biden administration announced that 24.2 million Americans enrolled in ACA marketplace plans for 2025 — the fifth consecutive record — just days before Trump took office. Both Fox News and NPR confirmed the milestone, while framing it differently ahead of expected Republican efforts to reduce ACA subsidies.
CMS, CNN, and Fox Business agreed that Medicare named another 15 high-cost drugs for price negotiation under the Inflation Reduction Act. The disagreement centered on whether the program lowers patient costs or distorts pharmaceutical incentives.
The FDA, CNN, and Fox News agreed that regulators revoked authorization for Red Dye No. 3 in food and ingested drugs. The split was mostly about how long the agency had delayed acting on older cancer findings.
